Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
- 1 September 2002
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 144 (3), 470-477
- https://doi.org/10.1067/mhj.2002.126115
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIJAMA, 2000
- Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapyAmerican Heart Journal, 2000
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996
- Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.Circulation, 1994